Five Reasons Your Margins May Be Wrong, and How to Fix Them - Register for Our Free Webinar

Five Reasons Your Margins May Be Wrong, and How to Fix Them - Register for Our Free Webinar

Aleafia Health Added to NYSE-Listed The Cannabis ETF | Cannabis Business Times

Sign in or create a free Cannabis Business Times account to continue reading

Continue to Site »
Site will load in 15 seconds

Continue to Site »X

Aleafia Health Added to NYSE-Listed The Cannabis ETF

The Cannabis ETF seeks to track the Innovation Labs Cannabis Index, a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries.

Posted by Melissa Schiller

July 11, 2019

TORONTO, July 11, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Aleafia Health Inc. has been added to The Cannabis ETF (NYSE: THCX), which trades on the New York Stock Exchange. THCX seeks to track the Innovation Labs Cannabis Index which is a portfolio of 35 stocks expected to benefit from growth of the legal marijuana, CBD and hemp industries.

“Aleafia Health welcomes the increased exposure to U.S. investors resulting from our addition to The Cannabis ETF,” said Aleafia Health CEO Geoffrey Benic. “This innovative ETF will serve as an important new avenue to tell the story of our highly differentiated global cannabis and wellness business."

8th Annual ‘Best Cannabis Companies to Work For’ Now Open for Entries

TerrAscend Reports $65M in Q3 Revenue; Net Loss of $9.5M

Green Thumb Industries Reports $291M in Q3 Revenue; Net Income of $23.3M

Curaleaf Reports $320M in Q3 Revenue; Net Loss of $54.5M

Verano Announces $195 Million Senior Secured Term Loan Refinancing Agreement

The new credit facility highlights the company’s ability to access lower-cost regional bank capital to fund strategic growth initiatives.

TerrAscend Reports $65M in Q3 Revenue; Net Loss of $9.5M

The cannabis company also reported its 13th consecutive quarter of positive cash flow from continuing operations.

Green Thumb Industries Reports $291M in Q3 Revenue; Net Income of $23.3M

The cannabis company also reported $74 million in cash flow from operations for the quarter.

Curaleaf Reports $320M in Q3 Revenue; Net Loss of $54.5M

The cannabis company also reported a year-to-date cash flow from operations of $104 million and a free cash flow of $57 million.

Cresco Labs Reports $165M in Q3 Revenue; Net Loss of $22M

The cannabis company also reported a third-quarter operating cash flow of $6 million.

Trulieve Reports $288M in Q3 Revenue; Net Loss of $27M

The cannabis company also reported a year-to-date cash flow from operations of $214 million and a free cash flow of $173 million.

Ascend Wellness Reports $127M in Q2 Net Revenue

The multistate cannabis operator also reported its 10th straight quarter of positive operating cash flow.

Trulieve Announces Registration Statement Filing

The cannabis company has no immediate plans to offer or sell any securities under the shelf registration.

Trulieve Resized

All 4Front Subsidiaries File for Court-Appointed Receiver

The company intends to continue operating during the receivership process and hopes the process will generate value for stakeholders.

4 Front Ventures Corp All 4 Front Subsidiaries File For Court App

Green Thumb Industries Reports $280M in Q1 Revenue

The cannabis company also reported $74 million in cash flow from operations and a GAAP net income of $8 million.

Green Thumb Image

Tilray Brands Announces Proposed Reverse Stock Split

The global cannabis company also announced a corresponding special stockholders meeting.

Tilray Brands Reports Quarterly Financial Results, Confirms No Tariff Impacts

The global cannabis company generated a net revenue of $186 million in the third fiscal quarter, verifying it has no current impacts from U.S. tariffs.

Page 1 of 184